217 related articles for article (PubMed ID: 32526631)
1. Analysis of neuronal iron deposits in Parkinson's disease brain tissue by synchrotron x-ray spectromicroscopy.
Brooks J; Everett J; Lermyte F; Tjendana Tjhin V; Sadler PJ; Telling N; Collingwood JF
J Trace Elem Med Biol; 2020 Dec; 62():126555. PubMed ID: 32526631
[TBL] [Abstract][Full Text] [Related]
2. Label-Free Nanoimaging of Neuromelanin in the Brain by Soft X-ray Spectromicroscopy.
Brooks J; Everett J; Lermyte F; Tjhin VT; Banerjee S; O'Connor PB; Morris CM; Sadler PJ; Telling ND; Collingwood JF
Angew Chem Int Ed Engl; 2020 Jul; 59(29):11984-11991. PubMed ID: 32227670
[TBL] [Abstract][Full Text] [Related]
3. XANES spectroscopy of a single neuron from a patient with Parkinson's disease.
Yoshida S; Ektessabi A; Fujisawa S
J Synchrotron Radiat; 2001 Mar; 8(Pt 2):998-1000. PubMed ID: 11513007
[TBL] [Abstract][Full Text] [Related]
4. Investigations of differences in iron oxidation state inside single neurons from substantia nigra of Parkinson's disease and control patients using the micro-XANES technique.
Chwiej J; Adamek D; Szczerbowska-Boruchowska M; Krygowska-Wajs A; Wojcik S; Falkenberg G; Manka A; Lankosz M
J Biol Inorg Chem; 2007 Feb; 12(2):204-11. PubMed ID: 17120075
[TBL] [Abstract][Full Text] [Related]
5. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.
Good PF; Olanow CW; Perl DP
Brain Res; 1992 Oct; 593(2):343-6. PubMed ID: 1450944
[TBL] [Abstract][Full Text] [Related]
6. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
Hirsch EC; Brandel JP; Galle P; Javoy-Agid F; Agid Y
J Neurochem; 1991 Feb; 56(2):446-51. PubMed ID: 1988548
[TBL] [Abstract][Full Text] [Related]
7. Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.
Faucheux BA; Martin ME; Beaumont C; Hauw JJ; Agid Y; Hirsch EC
J Neurochem; 2003 Sep; 86(5):1142-8. PubMed ID: 12911622
[TBL] [Abstract][Full Text] [Related]
8. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain.
Zecca L; Shima T; Stroppolo A; Goj C; Battiston GA; Gerbasi R; Sarna T; Swartz HM
Neuroscience; 1996 Jul; 73(2):407-15. PubMed ID: 8783258
[TBL] [Abstract][Full Text] [Related]
9. Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
Biesemeier A; Eibl O; Eswara S; Audinot JN; Wirtz T; Pezzoli G; Zucca FA; Zecca L; Schraermeyer U
J Neurochem; 2016 Jul; 138(2):339-53. PubMed ID: 27121280
[TBL] [Abstract][Full Text] [Related]
10. Intracellular chemical imaging of the developmental phases of human neuromelanin using synchrotron X-ray microspectroscopy.
Bohic S; Murphy K; Paulus W; Cloetens P; Salomé M; Susini J; Double K
Anal Chem; 2008 Dec; 80(24):9557-66. PubMed ID: 19007186
[TBL] [Abstract][Full Text] [Related]
11. Nano-imaging trace elements at organelle levels in substantia nigra overexpressing α-synuclein to model Parkinson's disease.
Lemelle L; Simionovici A; Colin P; Knott G; Bohic S; Cloetens P; Schneider BL
Commun Biol; 2020 Jul; 3(1):364. PubMed ID: 32647232
[TBL] [Abstract][Full Text] [Related]
12. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy.
Griffiths PD; Dobson BR; Jones GR; Clarke DT
Brain; 1999 Apr; 122 ( Pt 4)():667-73. PubMed ID: 10219780
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
14. The enigma of neuromelanin in Parkinson's disease substantia nigra.
Youdim MB; Ben-Shachar D; Riederer P
J Neural Transm Suppl; 1994; 43():113-22. PubMed ID: 7884393
[TBL] [Abstract][Full Text] [Related]
15. Total and paramagnetic metals in human substantia nigra and its neuromelanin.
Zecca L; Swartz HM
J Neural Transm Park Dis Dement Sect; 1993; 5(3):203-13. PubMed ID: 8396395
[TBL] [Abstract][Full Text] [Related]
16. Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson's disease.
Friedrich I; Reimann K; Jankuhn S; Kirilina E; Stieler J; Sonntag M; Meijer J; Weiskopf N; Reinert T; Arendt T; Morawski M
Acta Neuropathol Commun; 2021 Mar; 9(1):47. PubMed ID: 33752749
[TBL] [Abstract][Full Text] [Related]
17. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.
Zucca FA; Segura-Aguilar J; Ferrari E; Muñoz P; Paris I; Sulzer D; Sarna T; Casella L; Zecca L
Prog Neurobiol; 2017 Aug; 155():96-119. PubMed ID: 26455458
[TBL] [Abstract][Full Text] [Related]
18. Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis.
Carmona A; Carboni E; Gomes LC; Roudeau S; Maass F; Lenz C; Ortega R; Lingor P
J Neurochem; 2024 Feb; 168(2):128-141. PubMed ID: 38178798
[TBL] [Abstract][Full Text] [Related]
19. Pigmented creatine deposits in Amyotrophic Lateral Sclerosis central nervous system tissues identified by synchrotron Fourier Transform Infrared microspectroscopy and X-ray fluorescence spectromicroscopy.
Kastyak MZ; Szczerbowska-Boruchowska M; Adamek D; Tomik B; Lankosz M; Gough KM
Neuroscience; 2010 Apr; 166(4):1119-28. PubMed ID: 20097271
[TBL] [Abstract][Full Text] [Related]
20. Neuromelanin and Parkinson's disease.
Marsden CD
J Neural Transm Suppl; 1983; 19():121-41. PubMed ID: 6321645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
